| MARITIMA DEL CALLAO | 2025 | 17391.7 | KG | CIRALERG 2mg/5mL, CIRALERG, S/M CHLORPHENIRAMINE MALEATE ORAL SOLUTION 2mg/5mL-LOGO-I - Clorfenamina BATCH: 5PE50109-5PE51110// // MFG.DT.03.2025 - EXP.DT.02.2028 MEDICAMENTO DE USO HUMANO //5PE52143-5PE53144-5PE54145-5PE56147 // MFG.DT.04.2025 - EXP | INDIA | MOROCCO | 20283.2 |
| MARITIMA DEL CALLAO | 2025 | 7099.92 | KG | CIRALERG 2mg/5mL, CIRALERG, S/M CHLORPHENIRAMINE MALEATE ORAL SOLUTION 2mg/5mL-LOGO-I - Clorfenamina BATCH: 5PE49108-5PE50109 // MFG.DT.03.2025 - EXP.DT.02.2028 MEDICAMENTO DE USO HUMANO CIRALERG 2mg/5mL SOLUCION ORAL | INDIA | INDIA | 8480.67 |
| MARITIMA DEL CALLAO | 2025 | 1245.9 | KG | ATORVASTATINA 40mg, S/M, S/M ATORVASTATIN TABLETS 40mg-LOGO 1- Atorvastatina BATCH: 5E05105-5E06106-5E07107-5E08108-5E09109 // MFG.DT.02.2025 - EXP. DT. 01.2028 MEDICAMENTO DE USO HUMANO ATORVASTATINA 40mg TABLETAS RECUBIERTAS | INDIA | INDIA | 23794.9 |
| MARITIMA DEL CALLAO | 2025 | 609.67 | KG | ONDANSETRON 8mg/4mL, S/M, S/M ONDANSETRON INJECTION 8mg/4mL- (LOGO-1) -Ondansetrón BATCH: E01264-E02265// MFG.DT. 02.2025 - EXP.DT. 01.2028 MEDICAMENTO DE USO HUMANO ONDANSETRON 8mg/4mL SOLUCIÓN INYECTABLE | INDIA | MOROCCO | 12357.8 |
| MARITIMA DEL CALLAO | 2025 | 18543.9 | KG | CIRALERG 2mg/5mL, CIRALERG, S/M CHLORPHENIRAMINE MALEATE ORAL SOLUTION 2mg/5mL - LOGO-1- Clorfenamina BATCH: 5PE14027// MFG.DT.01.2025 - EXP.DT.12.2027 BATCH: 5PE15050-5PE16051-5PE17052-5PE18053-5PE19054 // MFG.DT.02.2025 - EXP.DT.01.2028// M CIRALER | INDIA | MOROCCO | 21628.8 |
| MARITIMA DEL CALLAO | 2025 | 849.456 | KG | CIROPROL 0.3%, CIROPROL, S/M CIROPROL (HYPROMELLOSE OPHTHALMIC SOLUTION USP 0.3% W/V)- WITHOUT LOGO-Hipromelosa BATCH: E04266-E03263 // MFG.DT.02.2025 - EXP. DT. 01.2028 MEDICAMENTO DE USO HUMANO CIROPROL 0.3% SOLUCION OFTALMICA | INDIA | MOROCCO | 12842.5 |
| MARITIMA DEL CALLAO | 2025 | 2491.8 | KG | ATORVASTATINA 40mg, S/M, S/M ATORVASTATIN TABLETS 40mg - Atorvastatina BATCH: 4E19750-4E20751-4E21752-4E22753-4E23754-4E24755-4E25756-4E26757-4E27758-4E28759 // MEDICAMENTO DE USO HUMANO ATORVASTATINA 40mg TABLETAS RECUBIERTAS | INDIA | MOROCCO | 48938.2 |
| MARITIMA DEL CALLAO | 2025 | 834.67 | KG | IBUPROFENO 400mg, S/M, S/M IBUPROFEN TABLETS BP 400mg - Ibuprofeno BATCH: 4E32813 // MFG.DT.12.2024 - EXP.DT.11.2027 MEDICAMENTO DE USO HUMANO IBUPROFENO 400mg TABLETAS RECUBIERTAS | INDIA | MOROCCO | 7625.48 |
| MARITIMA DEL CALLAO | 2025 | 200 | KG | SALBUTAMOL 5mg/mL, S/M, S/M SALBUTAMOL NEBULISER SOLUTION BP 5mg - Salbutamol BATCH: E06256 // MFG.DT. 12.2024 - EXP.DT. 11.2026 MEDICAMENTO DE USO HUMANO SALBUTAMOL 5mg/mL SOLUCION PARA NEBULIZACION | INDIA | MOROCCO | 4661.62 |
| MARITIMA DEL CALLAO | 2025 | 456.15 | KG | SALBUTAMOL 5mg/mL, S/M, S/M SALBUTAMOL NEBULISER SOLUTION BP 5mg - Salbutamol BATCH: E07257 // MFG.DT. 12.2024 - EXP.DT. 11.2026// E01258 // MFG.DT. 01.2025 - EXP.DT. 1 MEDICAMENTO DE USO HUMANO SE ACOGE AL NUMERAL 13 DEL ARTICULO 55 DE LA LEY No.27 | INDIA | MOROCCO | 10545.2 |
| MARITIMA DEL CALLAO | 2024 | 3612.25 | KG | WRAPIT 200mg/5mL, WRAPIT, S/M WRAPIT (AZITHROMYCIN FOR ORAL SUSPENSION USP 200MG/5ML) LOGO-1 - Azitromicina BATCH: 4EC01014 - 4EC02015 - 4EC03016 - 4EC04017 - 4EC05018 - 4EC06019 - 4EC07020 - 4EC080 MEDICAMENTO DE USO HUMANO WRAPIT 200mg/5mL POLVO PA | INDIA | INDIA | 38437 |
| MARITIMA DEL CALLAO | 2024 | 42.845 | KG | BUPIVACAINA CLORHIDRATO 0.5%, S/M, S/M BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP - Bupivacaína BATCH: E02231 // MFG.DATE:08.2023 - EXP. DATE:07.2026 MEDICAMENTO DE USO HUMANO SE ACOGE AL NUMERAL 13 DEL ARTICULO 55 DE LA LEY No.27444 ,BUPIVA | INDIA | INDIA | 1994.05 |
